series-b
Stage
1
Investors
About
Ngenebio develops next-generation sequencing (NGS)-based precision diagnostic products and software, focusing on oncology, infectious disease diagnostics, genomic data analysis, and integrated hospital data systems.
Explore Ngenebio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.